Get started
Author

Shohei Shiota

ORCID: 0009-0005-3104-385X
Observed ORCID: 0009-0005-3104-385X
OpenAlex ID: A5039433492
Fibrosis-3 Index: A New Score to Predict Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Without Age as a Factor
2022 · Kazuya Kariyama, Miwa Kawanaka, et al. · Gastro Hep Advances · 32
PDF
Chronological change in serum albumin as a prognostic factor in patients with hepatocellular carcinoma treated with lenvatinib: proposal of albumin simplified grading based on the modified albumin–bilirubin score (ALBS grade)
2022 · Kazuya Kariyama, Atsushi Hiraoka, et al. · Journal of Gastroenterology · 15
Impact of COVID‐19 pandemic on surveillance of hepatocellular carcinoma: A study in patients with chronic hepatitis C after sustained virologic response
2020 · Hidenori Toyoda, Satoshi Yasuda, et al. · GastroHep · 12
PDF
Pretreatment non‐hypervascular hypointense nodules on Gd‐EOB‐DTPA‐enhanced MRI as a predictor of hepatocellular carcinoma development after sustained virologic response in HCV infection
2021 · Hidenori Toyoda, Satoshi Yasuda, et al. · Alimentary Pharmacology & Therapeutics · 10
Early detection of hepatocellular carcinoma in patients with diabetes mellitus
2019 · Kazuhiro Nouso, Yoshie Furubayashi, et al. · European Journal of Gastroenterology & Hepatology · 10
Lack of hepatitis C virus reinfection in lifetime of Japanese general population with previous hepatitis C virus (HCV) infection successfully treated with anti-HCV therapy
2021 · Hidenori Toyoda, Satoshi Yasuda, et al. · Journal of Infection and Chemotherapy · 9
Identification of risk groups for advanced liver fibrosis in the general population using the Fibrosis‐3 index
2024 · Kazuya Kariyama, Miwa Kawanaka, et al. · JGH Open · 8
Safety, feasibility, and comfort of hepatic angiography and transarterial intervention with radial access for hepatocellular carcinoma
2021 · Hidenori Toyoda, Satoshi Yasuda, et al. · JGH Open · 6
PDF
Effect of butyrate‐producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab
2023 · Kazuhiro Nouso, Shohei Shiota, et al. · Cancer Medicine · 5
PDF
Treatment options for solitary hepatocellular carcinoma ≤5 cm: surgery vs. ablation: a multicenter retrospective study
2023 · Kazuya Kariyama, Kazuhiro Nouso, et al. · Journal of Liver Cancer · 4
PDF
Abnormal fucosylation of alpha‐fetoprotein in patients with nonalcoholic steatohepatitis
2021 · Kazuhiro Nouso, Yoshie Furubayashi, et al. · Hepatology Research · 3
Utility of the fibrosis-3 index for predicting liver fibrosis 5 years after achieving sustained virological response in patients with chronic hepatitis C
2025 · Kazuya Kariyama, Hidenori Toyoda, et al. · Clinics and Research in Hepatology and Gastroenterology · 2
Characteristics of cabozantinib treatment in advanced hepatocellular carcinoma
2023 · Kazuhiro Nouso, Shohei Shiota, et al. · Liver Cancer International · 2
Simple screening method for the diagnosis of nonB-nonC hepatocellular carcinoma
2018 · Kazuhiro Nouso, Yoshie Furubayashi, et al. · Hepatoma Research · 2
PDF
Identification of high-risk group for diabetes-associated hepatocellular carcinoma using noninvasive test for liver fibrosis
2025 · Kazuya Kariyama, Kazuhiro Nouso, et al. · European Journal of Gastroenterology & Hepatology · 1
Prognostic Efficacy of the Albumin Grade in Patients with Hepatocellular Carcinoma.
2024 · Yuichi Hirano, Kazuhiro Nouso, et al. · PubMed · 1
PDF
Identification of the suitable candidates for EOB-MRI with the high risk of the presence of non-hypervascular hypointense nodules in patients with HCV infection
2022 · Hidenori Toyoda, Satoshi Yasuda, et al. · European Radiology · 1
Long‐term persistence of hepatocarcinogenic potential of a non‐hypervascular hypointense nodule on EOB‐MRI after the eradication of hepatitis C virus
2021 · Hidenori Toyoda, Satoshi Yasuda, et al. · Hepatology Research · 1
Lower recurrence after ablation for MASLD-related versus alcohol-related hepatocellular carcinoma
2026 · Kazuya Kariyama, Akiko Wakuta, et al. · Journal of Liver Cancer
PDF
Effect of Butyrate‐Producing Enterobacteria and Proton Pump Inhibitors on Advanced Hepatocellular Carcinoma Treatment With Durvalumab and Tremelimumab
2026 · Kazuhiro Nouso, Akiko Wakuta, et al. · JGH Open
PDF
Usefulness of the Fibrosis-3 index in patients with hepatitis C
2025 · Kazuya Kariyama, Hidenori Toyoda, et al. · Annals of Medicine and Surgery
Editorial: is there a ‘precursor’ HCC lesion and can it be detected by hepatobiliary contrast‐enhanced magnetic resonance imaging? Authors' reply
2021 · Hidenori Toyoda, Satoshi Yasuda, et al. · Alimentary Pharmacology & Therapeutics
Author response for "Impact of COVID‐19 pandemic on surveillance of hepatocellular carcinoma: a study in patients with chronic hepatitis C after sustained virologic response"
2020 · Hidenori Toyoda, Satoshi Yasuda, et al. · Publons reviews and discussion
Works count: 23
Citation count: 124
H-index: 7
I10-index: 5
Year
Topic
Type